Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.97M | $2.0M | 4.09% | +44.0K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 1.71M | $2.0M | 3.54% | -- | 2026-06-30 |
| MARSHALL WACE, LLP | 1.60M | $1.0M | 3.31% | -415.0K | 2026-06-30 |
| BlackRock, Inc. | 1.45M | $1.0M | 3.01% | +39.0K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 668.8K | -- | 1.38% | +627.5K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 615.5K | -- | 1.27% | +19.3K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 485.0K | -- | 1.00% | -74.2K | 2026-06-30 |
| GMT Capital Corp | 450.1K | -- | 0.93% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 389.6K | -- | 0.81% | +62.8K | 2026-06-30 |
| Squarepoint Ops LLC | 318.4K | -- | 0.66% | +292.1K | 2026-06-30 |
